The prevalence of Type 2 diabetes and prediabetes is at an all-time high, with approximately 5 million people in the UK alone diagnosed with diabetes and nearly 14 million individuals at a high risk of developing the disease (prediabetes). Moreover, there are likely more undiagnosed cases, and these rates are continuously increasing.
The impact of this situation extends beyond the personal health and well-being burdens faced by individuals affected by complications such as amputations, vision loss, premature death, higher hospitalization rates, and increased likelihood of experiencing depression, among others. It also places significant financial strain on the NHS and other public services, accounting for about 10% of the total NHS budget.
There is an urgent need for scalable and effective treatment options. Weight management is recognized as a crucial therapeutic aspect for most individuals living with obesity and type 2 diabetes, highlighting the importance of having a range of effective weight management treatments available.
The health benefits associated with weight loss are noticeable even with a modest 5% reduction, and these benefits continue to increase with further weight loss. A weight loss of 7% can make a significant difference in preventing the development of type 2 diabetes. For individuals on the verge of diabetes, a weight loss of 7-8% can effectively bring them back from the brink.
These results will undoubtedly bring great satisfaction to the medical community, as they have the potential to significantly improve the health and well-being of their patients. It is crucial to acknowledge that obesity has far-reaching health implications, with over 200 possible complications affecting various organs and systems. Therefore, this weight loss will not only deliver individual health benefits but also contribute to overall health improvement and enhance quality of life.